Glaser Weil represented INVO Bioscience, Inc. on the merger agreement with NAYA Biosciences Inc., assisted by Pearl Cohen. INVO Bioscience, Inc. (Nasdaq: INVO), a global leader...
INVO Bioscience’s Reverse Merger with NAYA Biosciences
Waters Corporation’s $1.36 Billion Acquisition of Wyatt Technology
Kirkland & Ellis is advising Waters, while Glaser Weil is advising Wyatt. Waters Corporation (NYSE:WAT) announced it has entered into an agreement to acquire Wyatt Technology for...
Alumni Capital’s Equity Financing of NeuBase Therapeutics Inc.
Glaser Weil Fink Howard Avchen & Shapiro advised Alumni Capital Management on the deal. Alumni Capital Management announced an equity financing of Pittsburgh-based biotech company NeuBase Therapeutics...
Alumni Capital’s Equity Financing of Motorsport Games
Glaser Weil Fink Howard Avchen & Shapiro advised Alumni Capital on the deal. Alumni Capital Management announced an equity financing of Motorsport Games Inc. (NASDAQ: MSGM), a...